U.S. Chemicals Stock News

DRDGOLD (DRD) has drawn investor attention after reporting full year 2026 earnings, with sales of ZAR 11,159 million and net income of ZAR 4,255.5 million, alongside updated earnings guidance. See our latest analysis for DRDGOLD. Recent trading suggests investors are reacting strongly to DRDGOLD's full year 2026 update, with a 47.66% 30 day share price return and a 1 year total shareholder return of 76.5% indicating building momentum following a longer multiyear upswing. If the earnings move...

In the second quarter of 2026, Celcuity Inc. reported a net loss of US$78.86 million, or US$1.44 per share, with first-half net loss widening to US$131.71 million and loss per share reaching US$2.41, both higher than the same periods a year earlier. The sharp increase in reported losses underscores how Celcuity’s spending profile is evolving as it advances gedatolisib through clinical development and prepares for potential commercialization. With these larger recent losses in mind, we’ll now...

PulteGroup (PHM) moved back into focus after Wolfe Research upgraded the stock to Outperform, citing relatively resilient earnings forecasts and smaller projected cuts than for other covered homebuilders. See our latest analysis for PulteGroup. Against the Wolfe Research upgrade and recent earnings beat, PulteGroup’s share price has edged to US$129.61, with a 90-day share price return of 9.99% and a 3-year total shareholder return of 70.54%, suggesting momentum has been building over the...

Recent Share Performance and Business Snapshot Recent trading in National Beverage (FIZZ) has drawn attention after the stock moved about 2.2% higher in the latest session, with shorter term gains contrasting with longer term declines. Over the past week the share price is up about 6.6%, with an increase of roughly 7.7% over the past month. Over the past 3 months, however, the stock has declined about 7.2% and the total return over the past year is down about 15.6%. National Beverage...

Rubrik (RBRK) is in focus as the company heads into its next earnings report, with consensus pointing to quarterly earnings per share of US$0.04 and revenue of US$396.41 million. See our latest analysis for Rubrik. Rubrik's share price has eased in the very short term, with a 1-day share price return of 2.05% and a 7-day share price return of 2.95%. However, the 30-day and 90-day share price returns of 33.86% and 43.52% suggest momentum has been building ahead of earnings, while the 1-year...

Recently, Oscar Health was highlighted by Zacks as a top-ranked momentum and growth stock, citing its favorable Momentum and Growth Scores alongside an earnings-focused Zacks Rank #1. This recognition reflects how analysts currently view Oscar Health’s combination of earnings revisions, valuation metrics, and growth characteristics relative to its health insurance peers. We’ll now examine how Oscar Health’s new Zacks Rank #1 status and growth-screen inclusion may influence its existing...

Governance changes at AMC Entertainment Holdings AMC Entertainment Holdings (AMC) has put forward several corporate governance changes for a stockholder vote at its September 24, 2026 annual meeting, aiming to adjust how its board and investors share decision making power. See our latest analysis for AMC Entertainment Holdings. Alongside these proposed governance changes, AMC Entertainment Holdings has seen a 67.92% 90 day share price return and a 65.84% year to date share price return, while...

Natera (NTRA) is back on investor radar after Stanley Druckenmiller's family office made the stock its largest holding. This coincides with strong revenue growth, higher test volumes, and improving free cash flow. See our latest analysis for Natera. Natera’s recent news on clinical collaborations and higher test volumes sits alongside strong momentum in the stock. The 30 day share price return of 26.73% and 1 year total shareholder return of 104.36% point to building enthusiasm, while the...

Affiliated Managers Group (AMG) stock has recently attracted fresh attention, with investors weighing its latest trading performance and business profile in asset management in the context of broader market conditions and peer activity. See our latest analysis for Affiliated Managers Group. The current share price of Affiliated Managers Group at US$356.21 comes after a 1-day share price return of 1.02%, while the 90-day share price return of 15.41% and 1-year total shareholder return of...

Cummins (CMI) has drawn fresh attention after its Power Generation business was selected to supply battery energy storage systems for a large U.S. data center project focused on managing AI-driven power demand. See our latest analysis for Cummins. Despite the BESS announcement, Cummins’ share price has pulled back, with the 7 day share price return down 8.34% and the 30 day share price return down 11.58%. However, the 1 year total shareholder return of 50.54% points to momentum that has built...

Lennox International: Why Efficiency Metrics Are Back in Focus Fresh attention on Lennox International (LII) has been triggered by recent commentary highlighting its operating margin, free cash flow margin, and return on capital, which together are drawing closer scrutiny from investors. See our latest analysis for Lennox International. Lennox International's recent share price has come under pressure, with the 30 day share price return down 25.55% and the year to date share price return down...

ImmunityBio, Inc. recently appointed former World Bank president Dr. Jim Yong Kim as Vice Chairman, placing him in a newly created Office of the Executive Chairman to focus on global relationships with governments, health ministries, multilateral institutions, and other health partners. This move brings deep global health and development expertise directly into ImmunityBio’s leadership, potentially reshaping how the company pursues international access to its immunotherapy platform and...

With Treasury yields high, inflation still above 3% and the Federal Reserve’s next steps under close watch at Jackson Hole, investors are again questioning how much risk they really want to take. That uncertainty is pushing more attention toward high quality dividend stocks in defensive sectors that may handle prolonged higher rates differently. This article reveals three stocks exposed to these macro shifts and explains why each one could deserve a closer look right now. The stocks covered...

Alnylam Pharmaceuticals has had a difficult run over the past year, with the share price down 46.8%, while the current valuation checks still lean toward the stock being on the expensive side rather than a clear bargain. Over the past 12 months, Alnylam Pharmaceuticals shareholders have seen the stock decline 46.8%, which puts a spotlight on whether earlier optimism was too strong. Upcoming clinical data on RNAi programs like the transthyretin and hypertension studies can support sentiment...

In August 2026, Mattel announced a 3,509-piece, 1:1-scale buildable model of the original Microsoft XBOX under its Mattel Brick Shop premium brand, alongside new UNO Championship Series products that turn the classic card game into a competitive, tournament-style experience for home play. By pairing an adult-focused, high-end gaming collectible with a refreshed competitive format for one of its best-known family games, Mattel is broadening its reach across gamers, collectors, and large-group...

UMB Financial (UMBF) reported a strong second quarter, with revenue and earnings above expectations, supported by loan growth, solid asset quality, and higher fee income from monetizing investments. Despite this, the stock price reaction remained muted. See our latest analysis for UMB Financial. At a share price of US$145.14, UMB Financial has delivered a 24.61% year to date share price return. The 1 year total shareholder return of 22.10% and the very strong 3 year total shareholder return...

Ascendis Pharma earnings event and why it matters for shareholders Ascendis Pharma (NasdaqGS:ASND) recently reported second quarter 2026 results, with sales of €339.29 million and net income of €206.97 million, following a net loss in the same period a year earlier. See our latest analysis for Ascendis Pharma. Following the strong second quarter earnings shift into profitability, Ascendis Pharma's 7 day share price return of 2.38% and 90 day share price return of 5.69% suggest momentum has...

Leidos Holdings (LDOS) has secured a new five year, US$301 million contract to monitor U.S. military networks around the clock. The work extends its role in cyber defense for the Department of War. See our latest analysis for Leidos Holdings. At a share price of US$141.39, Leidos Holdings has seen a 30 day share price return of 26.08% and a 90 day share price return of 10.36%, while the 1 year total shareholder return is down 21.33% but up just over 50% across three and five years. This...

DoorDash (DASH) has been in focus after new partnerships with Barnes & Noble, Carter's, Kohl's, and Gap expanded its Marketplace into books, apparel, and broader back to school essentials for same day delivery. See our latest analysis for DoorDash. The latest partnerships come as DoorDash’s share price has gained momentum, with a 30 day share price return of 29.25% and a 90 day share price return of 45.12%, even though the 1 year total shareholder return declined 8.88% while the 3 year total...

Recent trading snapshot and return profile Essent Group (ESNT) recently closed at US$68.07, with the stock down about 0.7% on the day and 2% over the past week, yet up in the past month and past 3 months. For longer term holders, Essent Group shows a 10.4% total return over the past year, with multi year total returns above 40% over 3 years and above 60% over 5 years. See our latest analysis for Essent Group. For context, Essent Group’s short term share price momentum has cooled slightly...

Chipotle Mexican Grill (CMG) is drawing investor attention after announcing its first restaurant in Saudi Arabia later this month, in partnership with Alshaya Group. The move extends a growing presence across the Middle East. See our latest analysis for Chipotle Mexican Grill. The Saudi Arabia opening comes after a period of solid short term momentum for Chipotle Mexican Grill, with a 1 month share price return of 16.07% and a 90 day share price return of 14.21%, even as the 1 year total...

Visa stock has delivered a strong 66.7% return over the past 5 years, yet current checks suggest it no longer looks clearly cheap. The intrinsic value estimate from the Excess Returns model is broadly in line with the market price, while earnings-based multiples lean expensive. Recent news around antitrust litigation and new payment initiatives means investors are weighing solid past gains against what they are now paying for Visa’s future cash flows. A 66.7% gain over 5 years frames Visa as...

Neurocrine Biosciences stock has delivered a 59.0% return over the past five years, yet its current valuation checks still lean on the cheap side rather than pricing in a clear premium. That mix of solid long term performance and a strong value read is what investors now need to weigh. Over the past 5 years, Neurocrine Biosciences has returned 59.0%, which puts recent share price moves in the context of a stock that has already created meaningful value for long term holders. Fresh data from...

Dividend affirmation sets the stage for Pathward Financial stock discussion Pathward Financial (CASH) has affirmed a quarterly cash dividend of $0.05 per share for its fourth fiscal quarter of 2026, payable on October 1 to shareholders of record on September 10. See our latest analysis for Pathward Financial. Alongside the dividend affirmation, Pathward Financial’s recent trading has been steady rather than sharp, with the share price at US$83.68 and a year to date share price return of...